Inogen (INGN) Misses Q4 EPS by 16c, Revenues Miss; Offers FY20 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| INOGEN (NASDAQ: INGN) | Delayed: 7.27 +0.25 (3.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.02 | 52 Week High | $64.37 | |||
| Open | $7.13 | 52 Week Low | $28.81 | |||
| Day High | $7.44 | P/E | N/A | |||
| Day Low | $7.13 | EPS | $-0.36 | |||
| Volume | 215,460 | |||||
